Evotec and Exscientia Initiate Human Clinical Trials of their Novel Immuno-Oncology Drug
Published: Apr 9, 2021 | Tags: Evotec and Exscientia, Initiate, Human Clinical Trials, Novel, Immuno-Oncology Drug
Published: Apr 9, 2021 | Tags: PlantForm, Signs, Research, Development Agreement, Bio-Manguinhos/Fiocruz, Develop, Biosimilar Pembrolizumab
Published: Apr 9, 2021 | Tags: BMS, Reports, Results, Opdivo (nivolumab), Yervoy (ipilimumab), P-III CheckMate -648 Trial, Unresectable, Advanced, Metastatic, ESCC
Published: Apr 9, 2021 | Tags: Merck, Report, Results, Keytruda (pembrolizumab), P-III KEYNOTE-564 Trial, Adjuvant, Treatment, Renal Cell Carcinoma
Hologic to Acquire Mobidiag for ~ $795M
Published: Apr 9, 2021 | Tags: Hologic, Acquire, Mobidiag, ~ $795M
Published: Apr 9, 2021 | Tags: Biogen, Signs, License, Commercialization, Agreement, Bio-Thera, BAT1806 (biosimilar, tocilizumab), Treat, Moderate, Severe, Rheumatoid Arthritis
Published: Apr 8, 2021 | Tags: Lilly and Incyte, Report, Results, Baricitinib, P-III COV-BARRIER Study, Hospitalized, Patients, COVID-19
Published: Apr 8, 2021 | Tags: Daiichi Sankyo, Reports, First, Patient, Dosing, P- I/II Trial, DS-1594, Treat, Acute, Myeloid Leukemia, Acute Lymphoblastic Leukemia
Published: Apr 8, 2021 | Tags: Merck KGaA, Selects, PRA, Remote Patient Monitoring Platform, Human Growth Hormone Treatment System
Published: Apr 8, 2021 | Tags: AbbVie, Submits, Regulatory Applications, US, FDA, EMA, Skyrizi (risankizumab), Treat, Psoriatic Arthritis
Published: Apr 8, 2021 | Tags: Biogen, Tysabri (natalizumab, SC), Receives, EC, Marketing Authorization, Treat, Relapsing-Remitting, Multiple Sclerosis
BMS and PsiOxus Therapeutics Expand their 2016 Immuno-Oncology Collaboration
Published: Apr 8, 2021 | Tags: BMS and PsiOxus Therapeutics, Expand, 2016, Immuno-Oncology Collaboration
Novartis Collaborates with Artios Pharma to Discover Next Generation DDR Cancer Therapies
Published: Apr 7, 2021 | Tags: Novartis, Collaborates, Artios Pharma, Discover, Next Generation, DDR Cancer Therapies
Published: Apr 7, 2021 | Tags: J&J Vision, Collaborates, Menicon, Offer, Contact Lenses, Managing, Progression, Myopia, Children
AstraZeneca Collaborates with MGH to Accelerate Digital Health Solutions
Published: Apr 7, 2021 | Tags: AstraZeneca, Collaborates, MGH, Accelerate, Digital Health Solutions
Published: Apr 7, 2021 | Tags: Progenity, Signs , Agreement, Ionis Pharmaceuticals, Evaluate, Oral Biotherapeutics Delivery System, Antisense Oligonucleotides
Pear Sign a Multiple Agreements to Expands its Prescription Digital Therapeutic Platform
Published: Apr 7, 2021 | Tags: Pear, Sign, Multiple Agreements, Expands, Prescription Digital Therapeutic Platform
The US FDA Extends Review Period of Olumiant’s sNDA to Treat Moderate to Severe Atopic Dermatitis
Published: Apr 7, 2021 | Tags: US, FDA, Extends, Review Period, Olumiant, sNDA, Treat, Moderate, Severe, Atopic Dermatitis
Passage Bio’s PBKR03 Receives EC’s Orphan Drug Designation for Krabbe Disease
Published: Apr 6, 2021 | Tags: Passage Bio, PBKR03, Receives, EC, Orphan Drug Designation, Krabbe Disease
Horizon Presents Results of Uplizna (inebilizumab-cdon) in N-MOmentum Trial for NMOSD at AAN 2021
Published: Apr 6, 2021 | Tags: Horizon, Presents ,Results, Uplizna (inebilizumab-cdon), N-MOmentum Trial, NMOSD
Exelixis Reports the US FDA’s Acceptance of IND for XB002 in Patients with Advanced Solid Tumors
Published: Apr 6, 2021 | Tags: Exelixis, Reports, US, FDA, Acceptance, IND, XB002, Patients, Advanced, Solid Tumors
Published: Apr 6, 2021 | Tags: Ultragenyx, Collaborates, n-Lorem Foundation, Advance, Personalized, Medicines Treatment, Patients, Ultra-Rare Diseases
Welldoc Expands their Partnership with Dexcom to Offer Type 2 Diabetes Management Solution
Published: Apr 6, 2021 | Tags: Welldoc, Expands, Partnership, Dexcom, Offer, Type 2 Diabetes Management Solution
Sorrento to Acquire ACEA Therapeutics for ~$488M
Published: Apr 6, 2021 | Tags: Sorrento, Acquire, ACEA Therapeutics, ~$488M
Published: Apr 5, 2021 | Tags: uniQure, Reports, Completion, Enrollment, First, Cohort, P- I/II Trial, AMT-130, Treat, Huntington’s Disease
mAbxience’s MB02 (biosimilar, bevacizumab) Receives EC’s Approval for the Treatment of Cancer
Published: Apr 5, 2021 | Tags: mAbxience, MB02 (biosimilar, bevacizumab), Receives, EC, Approval, Treatment, Cancer
Published: Apr 5, 2021 | Tags: Taiho Oncology, Futibatinib (TAS-120), Receives, US, FDA Breakthrough Therapy Designation, Advanced, Cholangiocarcinoma
Published: Apr 5, 2021 | Tags: Lilly, Taltz (ixekizumab), Receives, Health Canada, Approval, Pediatri Patient, Moderate, Severe, Plaque Psoriasis
Gilead Expands its Collaboration with AbCellera to Develop Antibodies Against Multiple Indications
Published: Apr 5, 2021 | Tags: Gilead, Expands, Collaboration, AbCellera, Develop, Antibodies, Against, Multiple Indications
Merck KGaA Exercises Third Option in its Immuno-Oncology Collaboration with F- star
Published: Apr 5, 2021 | Tags: Merck KGaA, Exercises, Third Option, Immuno-Oncology, Collaboration, F- star
Related Post: PharmaShots Weekly Snapshots (Mar 29 – Apr 02, 2021)
The post PharmaShots Weekly Snapshots (Apr 05 – 09, 2021) first appeared on PharmaShots.